One in three people who experience symptomatic Covid-19 suffer from hair loss.
Leading medical professionals worldwide are turning to a new technology in the form of CALECIM® Professional Advanced Hair System as the go-to solution. This six-week hair restoration program is the only treatment that has been clinically proven to have positive results on Telogen Effluvium caused by Covid-19.
PTT-6®, the active ingredient of the hair system, is a complex mix of growth factors, peptides, cytokines, and exosomes derived from ethically sourced stem cells. It has been proven to increase dermal papilla cell proliferation by 24% and reduce the levels of proinflammatory cytokine tumour necrosis factor alpha (TNF- α) by 30x with no reported side effects.
PTT-6® was featured in a recent PMFA article co-authored by leading hair restoration expert, Dr Neil Sadick, as a revolutionary treatment solution for other forms of hair loss, such as Androgenetic Alopecia and Alopecia Areata. For the treatment of Telogen Effluvium, it has been shown to significantly increase hair regrowth and improve hair density.
The CALECIM® Advanced Hair System can be offered as a procedure in-clinic with an at-home application option. It offers a radical new treatment for hair restoration, offering a clinically validated solution that addresses a spectrum of hair loss challenges.
For further information and inquiries, please contact: firstname.lastname@example.org
Sales & Client Relations
T: +65 89494510